DBD Diebold Nixdorf (DBD) Insider Trading, Ownership & Congress Trades
Tech Hardware · Calculating & accounting machines (no electronic computers) · CIK 0000028823
Cluster · 3 insidersC-suite buying · 3
House members buying, 1 year
0
STOCK Act, US House only, disclosed up to 45 days after the trade
Funds added, last quarter
129
13F, latest reported quarter
What the filings say about DBD
Insiders, 180 days
-$49.7M net sold
3 buyers · 2 sellers · 0% of sales under a 10b5-1 plan
Diebold Nixdorf insider trades (Form 4)
Form 4 buys and sells (codes P and S). Grants, option exercises
and conversions excluded.
Over the last 180 days, DIEBOLD NIXDORF, Inc insiders sold a net $49.7M of stock across 91 Form 4 purchases and sales, with 3 insiders buying. Source: SEC Form 4 filings, as of 2026-10-28.
Insider
Filed
Shares
Value
Since filing
Context
- 3 earlier Form 4 trades (code P or S) here by this insider (3 buys), the last on May 22, 2026.
- +8.8% median (+4.6% mean) 90-day return after 3 previous buys.
- The trade is 22.3% of the 3,132 shares held after it.
- No other insider bought within 30 days.
- 129 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: EVP, CFO Timko Thomas S bought about $50.6K of DBD on Jul 31, 2026; 129 funds added in the latest 13F quarter.Context
- 6 earlier Form 4 trades (code P or S) here by this insider (6 sales), the last on Jun 25, 2026.
- The trade is 2.4% of the 4,104,432 shares held after it.
- 1 other insider sold within 30 days.
- 129 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Insider Connolly Brian D sold about $8.5M of DBD on Jun 26, 2026; 1 other insider sold within 30 days and 129 funds added in the latest 13F quarter.Context
- 5 earlier Form 4 trades (code P or S) here by this insider (5 sales), the last on Jun 24, 2026.
- The trade is 0.1% of the 4,204,432 shares held after it.
- 1 other insider sold within 30 days.
- 129 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Insider Connolly Brian D sold about $233.1K of DBD on Jun 25, 2026; 1 other insider sold within 30 days and 129 funds added in the latest 13F quarter.Context
- 4 earlier Form 4 trades (code P or S) here by this insider (4 sales), the last on Jun 15, 2026.
- The trade is 5.4% of the 4,207,173 shares held after it.
- 1 other insider sold within 30 days.
- 129 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Insider Connolly Brian D sold about $19.2M of DBD on Jun 24, 2026; 1 other insider sold within 30 days and 129 funds added in the latest 13F quarter.Context
- 3 earlier Form 4 trades (code P or S) here by this insider (3 sales), the last on Jun 12, 2026.
- The trade is 0.0% of the 4,435,896 shares held after it.
- 1 other insider sold within 30 days.
- 129 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Insider Connolly Brian D sold about $148.1K of DBD on Jun 15, 2026; 1 other insider sold within 30 days and 129 funds added in the latest 13F quarter.91 transactions on record
Since filing: total return from the first close after the filing to the latest close, dividend-adjusted. Not a forecast.
Context lines are counts over the filings above and returns from our own price history, never a price level. Not investment advice.
Seven facts, ranked against the sector ·
Rank is not a forecast
Insiders
net -$49.7M over 180 days
+$50.6K over 90 days · -$50.0M of it by a 10%+ holder
below 87% of Tech Hardware
Congress
no House purchase disclosed in the last 12 months
Funds
129 funds bought in last quarter
more than 53% of Tech Hardware
Revenue
+1.5% year over year
below 72% of Tech Hardware
Margin
2.5% net margin
more than 58% of Tech Hardware
Buybacks
$121.0M repurchased, FY to 2026-06-30
more than 56% of Tech Hardware
Short interest
11.3% of the float short (float per yahoo 2026-10-26) · 13.3 days to cover · settled 2026-09-30
more than 78% of Tech Hardware
What changed in the last 30 days
Oct 28Insider selling stopped: no sales in 90 days after 8 in the prior 90
Why it matters
The absence is the signal: 8 sales in one 90-day window and none in the next is a change of behaviour, not a filing.
Watch DBD
A free account keeps a watchlist and can send one email a day when insiders, funds or Congress file on the names in it. No password and no card.
The year, with the filings on it
Total return over 12 months. Each marker is a filing; hover or tap one for the detail.
+19.0%12M
Insider buyInsider sell
Indexed to 100, dividend-adjusted, not a price chart.
When a name files heavily, the largest trades are drawn first.
Who owns DBD: institutional holders (13F)
13F holdings, latest reported quarter
11,552,095 sh
$982.2M
4,554,469 sh
$387.2M
4,104,432 sh
$349.0M
1,379,553 sh
$117.3M
1,296,672 sh
$110.2M
Congress trades in DBD
No Congress trades reported
No House member has disclosed a trade in this stock. See what Congress is buying.
Activist and 5% holders (13D/13G)
No 5%+ ownership filings
Nobody has filed for crossing 5%. That is a fact, not missing data.
DBD planned insider sales (Form 144)
No planned-sale notices
No insider has filed to sell. Watch this after a run-up.
DBD mutual fund holders (N-PORT)
Funds ranked by the share of their own portfolio in this stock (N-PORT).
William Blair Small Cap Growth Fund
$28.0M position · as of 2026-06-30
2.3%
Royce Small-Cap Value Fund
$2.5M position · as of 2026-06-30
2.2%
Royce Capital Fund - Small-Cap Portfolio
$4.0M position · as of 2026-06-30
2.2%
Hennessy Cornerstone Growth Fund
$9.4M position · as of 2026-07-31
1.9%
American High Income Trust
$15.6M position · as of 2026-06-30
1.7%
American High Income Trust
$495.5M position · as of 2026-06-30
1.7%
SEC N-PORT, monthly, about 60 days late · funds ≥ $10M ·
% is the share of the fund's own portfolio
Live price
Daily candles from TradingView, under their licence. No filings marked.
Why this name is on the desk
3 insiders reported buying shares.
The record shows a net $49.7M sold by insiders over 180 days, 129 funds added last quarter. Each figure is a federal filing, dated the day it went public.
DBD financials
Revenue growth
+1.5%
XBRL, annual
Net margin
2.5%
Ratios from the company's XBRL filings, latest filings
Revenue, TTM
$3.9B
four quarters, 2025-07-01 to 2026-06-30
Revenue, TTM DBD
| FY Dec 2025 | $3.8B |
| FY Dec 2024 | $3.8B |
| FY Dec 2022 | $3.5B |
| FY Dec 2021 | $3.9B |
| FY Dec 2020 | $3.9B |
| Jun 2026 | $930.8M |
| Mar 2026 | $891.8M |
| Dec 2025 | $1.1B |
| Sep 2025 | $945.2M |
| Jun 2025 | $915.2M |
| Mar 2025 | $841.1M |
| Dec 2024 | $988.9M |
| Sep 2024 | $927.1M |
At each fiscal year end
Single quarter
Net margin, TTM
+2.9%
net income over revenue, 2025-07-01 to 2026-06-30
Net margin, TTM DBD
| FY Dec 2025 | +2.5% |
| FY Dec 2024 | -0.4% |
| FY Dec 2022 | -16.8% |
| FY Dec 2021 | -2.0% |
| FY Dec 2020 | -6.9% |
| Jun 2026 | +1.7% |
| Mar 2026 | +0.6% |
| Dec 2025 | +4.5% |
| Sep 2025 | +4.3% |
| Jun 2025 | +1.3% |
| Mar 2025 | -1.0% |
| Dec 2024 | +0.6% |
| Sep 2024 | -2.4% |
At each fiscal year end
Single quarter
Free cash flow, TTM
$277.7M
operating cash flow minus capex, 2025-07-01 to 2026-06-30
Free cash flow, TTM DBD
| FY Dec 2025 | $305.4M |
| FY Dec 2024 | $153.9M |
| FY Dec 2022 | -$383.2M |
| FY Dec 2021 | $128.0M |
| FY Dec 2020 | $22.7M |
| Jun 2026 | n/a |
| Mar 2026 | n/a |
| Dec 2025 | n/a |
| Sep 2025 | n/a |
| Jun 2025 | n/a |
| Mar 2025 | n/a |
| Dec 2024 | n/a |
| Sep 2024 | n/a |
At each fiscal year end
Single quarter
Debt to equity
0.97x
long-term 2026-06-30 plus current 2025-03-31 (15 months older than the period end); equity 2026-06-30
Debt to equity DBD
| FY Dec 2025 | 0.85x |
| FY Dec 2024 | 1.00x |
| FY Dec 2022 | n/a |
| FY Dec 2021 | n/a |
| FY Dec 2020 | n/a |
| Jun 2026 | 0.97x |
| Mar 2026 | 0.92x |
| Dec 2025 | 0.85x |
| Sep 2025 | 0.84x |
| Jun 2025 | 0.85x |
| Mar 2025 | 0.94x |
| Dec 2024 | 1.00x |
| Sep 2024 | 1.00x |
At each fiscal year end
Trailing four quarters at each quarter end
Cash flow to debt
0.29x
TTM operating cash flow over long-term 2026-06-30 plus current 2025-03-31 (15 months older than the period end)
Cash flow to debt DBD
| FY Dec 2025 | 0.32x |
| FY Dec 2024 | 0.16x |
| FY Dec 2022 | -0.15x |
| FY Dec 2021 | 0.05x |
| FY Dec 2020 | 0.01x |
| Jun 2026 | 0.29x |
| Mar 2026 | 0.34x |
| Dec 2025 | 0.32x |
| Sep 2025 | 0.30x |
| Jun 2025 | 0.24x |
| Mar 2025 | 0.20x |
| Dec 2024 | 0.16x |
| Sep 2024 | n/a |
At each fiscal year end
Trailing four quarters at each quarter end
Return on equity
+10.8%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on equity DBD
| FY Dec 2025 | +9.3% |
| FY Dec 2024 | -1.7% |
| FY Dec 2022 | n/a |
| FY Dec 2021 | n/a |
| FY Dec 2020 | n/a |
| Jun 2026 | +10.8% |
| Mar 2026 | +10.8% |
| Dec 2025 | +9.3% |
| Sep 2025 | +4.7% |
| Jun 2025 | -1.2% |
| Mar 2025 | -1.0% |
| Dec 2024 | -1.7% |
| Sep 2024 | n/a |
At each fiscal year end
Trailing four quarters at each quarter end
Return on assets
+3.0%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on assets DBD
| FY Dec 2025 | +2.6% |
| FY Dec 2024 | -0.4% |
| FY Dec 2022 | -17.7% |
| FY Dec 2021 | -2.2% |
| FY Dec 2020 | -7.2% |
| Jun 2026 | +3.0% |
| Mar 2026 | +2.9% |
| Dec 2025 | +2.6% |
| Sep 2025 | +1.3% |
| Jun 2025 | -0.3% |
| Mar 2025 | -0.3% |
| Dec 2024 | -0.4% |
| Sep 2024 | n/a |
At each fiscal year end
Trailing four quarters at each quarter end
Return on invested capital
+10.7%
operating income after a 28.3% effective tax rate, over long-term 2026-06-30 plus current 2025-03-31 (15 months older than the period end) plus average of 2025-06-30 and 2026-06-30 minus cash
Return on invested capital DBD
| FY Dec 2025 | +12.0% |
| FY Dec 2024 | n/a |
| FY Dec 2022 | n/a |
| FY Dec 2021 | n/a |
| FY Dec 2020 | n/a |
| Jun 2026 | +10.7% |
| Mar 2026 | +11.9% |
| Dec 2025 | +12.0% |
| Sep 2025 | +8.4% |
| Jun 2025 | n/a |
| Mar 2025 | n/a |
| Dec 2024 | n/a |
| Sep 2024 | n/a |
At each fiscal year end
Trailing four quarters at each quarter end
Return on capital employed
+10.2%
operating income (EBIT proxy) over average of 2025-06-30 and 2026-06-30 minus current liabilities
Return on capital employed DBD
| FY Dec 2025 | +10.2% |
| FY Dec 2024 | +7.3% |
| FY Dec 2022 | -13.2% |
| FY Dec 2021 | +7.3% |
| FY Dec 2020 | +1.1% |
| Jun 2026 | +10.2% |
| Mar 2026 | +10.3% |
| Dec 2025 | +10.2% |
| Sep 2025 | +8.0% |
| Jun 2025 | +7.0% |
| Mar 2025 | +7.7% |
| Dec 2024 | +7.3% |
| Sep 2024 | n/a |
At each fiscal year end
Trailing four quarters at each quarter end
P/E, trailing
22.71x
close 2026-10-26 over four quarters of diluted EPS, 2025-07-01 to 2026-06-30
P/E, trailing DBD
| FY Dec 2025 | 26.52x |
| FY Dec 2024 | n/a |
| FY Dec 2022 | n/a |
| FY Dec 2021 | n/a |
| FY Dec 2020 | n/a |
| Jun 2026 | 28.06x |
| Mar 2026 | 25.84x |
| Dec 2025 | 26.52x |
| Sep 2025 | 41.63x |
| Jun 2025 | n/a |
| Mar 2025 | n/a |
| Dec 2024 | n/a |
| Sep 2024 | n/a |
At each fiscal year end
Trailing four quarters at each quarter end
Enterprise value
$2.9B
market value at close 2026-10-26 on 2026-07-21 shares, plus long-term 2026-06-30 plus current 2025-03-31 (15 months older than the period end), minus cash 2026-03-31
Enterprise value DBD
| FY Dec 2025 | $3.0B |
| FY Dec 2024 | $2.2B |
| FY Dec 2022 | n/a |
| FY Dec 2021 | n/a |
| FY Dec 2020 | n/a |
| Jun 2026 | $3.5B |
| Mar 2026 | $3.2B |
| Dec 2025 | $3.0B |
| Sep 2025 | $2.8B |
| Jun 2025 | $2.7B |
| Mar 2025 | $2.3B |
| Dec 2024 | $2.2B |
| Sep 2024 | $2.5B |
At each fiscal year end
Trailing four quarters at each quarter end
FCF yield
+11.9%
TTM free cash flow over market value at close 2026-10-26
FCF yield DBD
| FY Dec 2025 | +12.5% |
| FY Dec 2024 | +9.5% |
| FY Dec 2022 | n/a |
| FY Dec 2021 | n/a |
| FY Dec 2020 | n/a |
| Jun 2026 | +9.4% |
| Mar 2026 | +12.1% |
| Dec 2025 | +12.5% |
| Sep 2025 | +13.6% |
| Jun 2025 | +11.2% |
| Mar 2025 | +11.7% |
| Dec 2024 | +9.5% |
| Sep 2024 | n/a |
At each fiscal year end
Trailing four quarters at each quarter end
PEG, trailing
n/a
prior-year trailing EPS was a loss, growth undefined
PEG, trailing DBD
| FY Dec 2025 | n/a |
| FY Dec 2024 | n/a |
| FY Dec 2022 | n/a |
| FY Dec 2021 | n/a |
| FY Dec 2020 | n/a |
| Jun 2026 | n/a |
| Mar 2026 | n/a |
| Dec 2025 | n/a |
| Sep 2025 | n/a |
| Jun 2025 | n/a |
| Mar 2025 | n/a |
| Dec 2024 | n/a |
| Sep 2024 | n/a |
At each fiscal year end
Trailing four quarters at each quarter end
Price as of 2026-10-26. Hover or tap a tile for its yearly and quarterly history.
Method
TTM is four consecutive fiscal quarters; Q4 is the year minus nine months when not filed. Returns use the average of opening and closing balances. EBIT is approximated by operating income. PEG uses trailing EPS growth.
Fundamentals
Annual figures from XBRL filings. Pick a past date to see them as known then.
| 2025-12 | 2024-12 | 2023-12 | 2023-08 | |
|---|---|---|---|---|
| Revenue | $3.8B | $3.8B | n/a | n/a |
| Gross profit | $961.2M | $920.0M | n/a | n/a |
| Operating income | $242.0M | $182.1M | n/a | n/a |
| Net income | $94.6M | -$16.5M | n/a | n/a |
| EPS (diluted) | 2.54 | -0.44 | n/a | n/a |
| Operating cash flow | $300.7M | $149.2M | n/a | n/a |
| Cash | $368.9M | $296.2M | $550.2M | $391.4M |
| Long-term debt | $938.5M | $927.3M | $1.3B | $1.3B |
| Buybacks | $130.7M | $0 | n/a | n/a |
SEC XBRL, fiscal years, as known on 2026-10-28
DBD Stock Sonar score 6/7 axes
Find similar shapesCompareDBD ranks highest on profitability (57th percentile) and insider conviction (54th), and lowest on risk and compliance (25th), among Tech Hardware peers.
6 of 7 axes scored. Each is a percentile against sector peers (all companies when the sector is thin); higher is better. An unscored axis is unmeasured, not low. How it is scored
DBD filings, in plain words
Are Diebold Nixdorf insiders buying or selling DBD?
In the 180 days to 2026-10-28, Diebold Nixdorf insiders were net sellers, a net $49.7M: $299.7K of purchases and $50.0M of sales reported on Form 4, by 3 buyers and 2 sellers.
Read the full summary
In the 180 days to 2026-10-28, Diebold Nixdorf insiders were net sellers of DBD, a net $49.7M across purchases and sales reported on Form 4 by 3 buyers and 2 sellers. Most of that figure, $50.0M, came from a holder of 10% or more rather than an officer or director. Sales outweighed purchases more than tenfold by value. 3 insiders reported purchases in that window. None of the 8 insider sales was flagged as made under a Rule 10b5-1 plan. Each figure is counted from SEC and House filings as of 2026-10-28, dated the day the filing was made public.
Explore insider trading and ownership data
Every company we track, ranked by each kind of filing
